Trevena, Inc. CEO To Present At The Jefferies and Co. 2015 Global Healthcare Conference

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced Maxine Gowen, Ph.D., its chief executive officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Wednesday June 3, 2015 at 3:00 p.m. EDT in New York.

Help employers find you! Check out all the jobs and post your resume.

Back to news